February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Crapo Applauds Bipartisan, Bicameral Finance Committee Priorities in Government Funding Bill
- Working Families Tax Cuts Fuel American Manufacturing
- Working Families Tax Cuts Bring Bigger Paychecks
- Senate Republicans Blast Tim Walz for Rampant Child Care Fraud, Demand Accountability for American Taxpayers
- Americans Win with the Working Families Tax Cuts